substance use in transgender individuals myo thwin myint, m.d., f.a.a.p. department of psychiatry...

51
Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane University School of Medicine

Upload: maurice-phelps

Post on 21-Dec-2015

216 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Substance Use in Transgender Individuals

Myo Thwin Myint, M.D., F.A.A.P.

Department of Psychiatry & Behavioral SciencesDepartment of Pediatrics

Tulane University School of Medicine

Page 2: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Introduction

Sex◦Biological indicators

◦Males & females

Gender◦Public lived roles

◦Boy/man & girl/woman

© Alcohol Medical Scholars Program 2

Page 3: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

When Mismatch OccursStigma

Prejudice & discrimination

Physical/sexual abuse/neglect

Minority stress

Psychological stress

Mental health problems

Alcohol & drug problems

3© Alcohol Medical Scholars Program

Page 4: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Outline

Definitions

Characteristics of transgender

Psychiatric & substance use D/O

Treatments

4© Alcohol Medical Scholars Program

Page 5: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Outline

Definitions

Characteristics of transgender

Psychiatric & substance use D/O

Treatments

5© Alcohol Medical Scholars Program

Page 6: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Gender IdentityGender Identity

Alternative

© Alcohol Medical Scholars Program 6

Page 7: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Trans…Trans…

Transgender: identity ≠ natal sex

Transexual: undergone transition

Transvestism: cross-dressing

© Alcohol Medical Scholars Program 7

Page 8: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Sexual OrientationSexual Orientation

Androphilia: to ♂

Gynephilia: to ♀

© Alcohol Medical Scholars Program 8

Page 9: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Outline

Definitions

Characteristics of transgender

Psychiatric & substance use D/O

Treatments

9© Alcohol Medical Scholars Program

Page 10: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Gender Dysphoria (DSM-5)Children: 6+ for 6+ months

◦Desire being other gender◦Cross-dressing◦Cross-gender roles in play◦Preference in toys of other gender◦Other gender playmates◦Rejection of typical natal gender toys

◦Dislike of one’s sexual anatomy◦Desire for characteristics of other

Must → distress/impairment10

© Alcohol Medical Scholars Program

Page 11: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Gender Dysphoria (DSM-5)Adol./Adults: 2+ for 6+ months

◦Incongruence

◦Desire to be rid of one’s sex characters

◦Desire for other gender’s sex characters

◦Desire to be other gender

◦Desire to be treated as other gender

◦Having feelings of other genderMust → distress/impairment

11© Alcohol Medical Scholars Program

Page 12: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Gender Gender NoncomformityNoncomformityNot = gender dysphoria

Gender conformity:Behavior/appearance as society expects

Gender nonconformity:Acting gender atypical by society

© Alcohol Medical Scholars Program 12

Page 13: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Gender Gender NoncomformityNoncomformityNot indicative of sexual orientation

Can apply to people w/o distress

Varies w/ time & place© Alcohol Medical Scholars Program 13

Page 14: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Gender DysphoriaGender Dysphoria

Only some transgender individual

At times of significant distress

Related to gender incongruence© Alcohol Medical Scholars Program 14

Page 15: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Diversity, Not Diversity, Not Pathology Pathology

© Alcohol Medical Scholars Program 15

Page 16: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

PrevalencePrevalence

0.01% natal ♂

0.003% natal ♀

© Alcohol Medical Scholars Program 16

Page 17: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Course: PersistersCourse: Persisters

30% natal ♂

50% natal ♀

Predictors◦Intensity of early dysphoria◦Seen in adolescents

© Alcohol Medical Scholars Program 17

Page 18: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Course: DesistersCourse: Desisters

Natal ♂◦Androphilic attraction◦Self identify as gay/homosexual

Natal ♀ ◦Gynephilic attraction◦Self identify as lesbian

© Alcohol Medical Scholars Program 18

Page 19: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Course: Late OnsetCourse: Late Onset

Natal ♂◦Transvestic behavior ◦Gynephilic attraction◦Self identify as lesbian post transition

Natal ♀ ◦No transvestic behavior◦Androphilic attraction◦Self identify as gay post transition

© Alcohol Medical Scholars Program 19

Page 20: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

© Alcohol Medical Scholars Program 20

Page 21: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Differential DiagnosisDifferential Diagnosis

Gender roles noncomformity:◦Tomboyism◦Girly-boy

Transvestic disorder (D/O)◦Cross dressing for sexual excitement

◦Causes distress/impairment© Alcohol Medical Scholars Program 21

Page 22: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Differential DiagnosisDifferential Diagnosis

Body dysmorphic D/O◦Thinking body parts are not well-formed

◦Focusing on alteration/removal

Schizophrenic & other psychotic D/O◦Hearing voices/paranoia◦Rare to have gender delusion only

© Alcohol Medical Scholars Program 22

Page 23: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Outline

Definitions

Characteristics of transgender

Psychiatric & substance use D/O

Treatments

23© Alcohol Medical Scholars Program

Page 24: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Prevalence: Any Prevalence: Any Psych. DxPsych. Dx

70% Lifetime

40% Current

© Alcohol Medical Scholars Program 24

Page 25: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Prevalence: SuicidePrevalence: Suicide

© Alcohol Medical Scholars Program 25

W/ MDDTrans-gender

General populatio

n

Ideation 60% 40%

Attempt 30% 10%

Page 26: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Prevalence: Psych. DxPrevalence: Psych. Dx

© Alcohol Medical Scholars Program 26

D/OTrans-gender

General populatio

n

Socialanxiety

7%

Page 27: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Prevalence: Psych. DxPrevalence: Psych. Dx

© Alcohol Medical Scholars Program 27

D/OTrans-gender

General populatio

n

Socialanxiety

45% 7%

Page 28: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Prevalence: Psych. DxPrevalence: Psych. Dx

© Alcohol Medical Scholars Program 28

D/OTrans-gender

General populatio

nSocial

anxiety45% 7%

Major depressi

ve7%

Page 29: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Prevalence: Psych. DxPrevalence: Psych. Dx

© Alcohol Medical Scholars Program 29

D/OTrans-gender

General populatio

nSocial

anxiety45% 7%

Major depressi

ve26% 7%

Page 30: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Prevalence: Psych. DxPrevalence: Psych. Dx

© Alcohol Medical Scholars Program 30

D/OTrans-gender

General populatio

nSocial

anxiety45% 7%

Major depressi

ve26% 7%

PTSD 9%

Page 31: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Prevalence: Psych. DxPrevalence: Psych. Dx

© Alcohol Medical Scholars Program 31

D/OTrans-gender

General populatio

nSocial

anxiety45% 7%

Major depressi

ve26% 7%

PTSD 13% 9%

Page 32: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Prevalence: Substance Prevalence: Substance UseUse

© Alcohol Medical Scholars Program 32

Trans-gender

General populatio

n

Cocaine 40% 15%

Page 33: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Prevalence: Substance Prevalence: Substance UseUse

© Alcohol Medical Scholars Program 33

Trans-gender

General populatio

n

Cocaine 40% 15%

Meth > 40% 5%

Page 34: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Prevalence: Substance Prevalence: Substance UseUse

© Alcohol Medical Scholars Program 34

Trans-gender

General populatio

n

Cocaine 40% 15%

Meth > 40% 5%

IV drugs 40% 25%

Page 35: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Prevalence: Substance Prevalence: Substance UseUse

© Alcohol Medical Scholars Program 35

Trans-gender

General populatio

n

Cocaine 40% 15%

Meth > 40% 5%

IV drugs 40% 25%

Tobacco 70% 20%

Page 36: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Outline

Definitions

Characteristics of transgender

Psychiatric & substance use D/O

Treatments

36© Alcohol Medical Scholars Program

Page 37: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

© Alcohol Medical Scholars Program 37

Page 38: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Physical Rx: HormonesEstrogen for ♂ → ♀

Testosterone ♀ → ♂

Suppressors to block puberty

High rate of use w/o supervision

38© Alcohol Medical Scholars Program

Page 39: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Physical Rx: Hormones

Possible side effects◦Hypomania/mania◦Psychosis

Interactions w/ substance use◦Smoking + estrogen → risk of clot

◦Smoking + testosterone → risk of heart disease

39© Alcohol Medical Scholars Program

Page 40: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Physical Rx: Surgery

Irreversible

Only 1-2% regret

Improves dysphoria sx & psych fxn

40© Alcohol Medical Scholars Program

Page 41: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

© Alcohol Medical Scholars Program 41

Page 42: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Psychotherapy

Explore identity, role, expression

Address negative impact

Alleviate internalized hatred

Enhance support

Improve body image

Promote resilience42

© Alcohol Medical Scholars Program

Page 43: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Psychosocial Rx

Voice & communication therapy

Hair removal

Learn to dress as identified gender

43© Alcohol Medical Scholars Program

Page 44: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Rx BarriersDiscrimination

Hostility & insensitivity

Strict binary gender segregation

Lack of group acceptance 44

© Alcohol Medical Scholars Program

Page 45: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Primary CarePediatricians

Family Medicine

Internists

Coordinating care

45© Alcohol Medical Scholars Program

Page 46: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Mental Health

Assess comorbid diagnoses

Monitor psychiatric sx

46© Alcohol Medical Scholars Program

Page 47: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Other Rx SpecialistsOther Rx SpecialistsEndocrinologists

Urologists

Gynecologists

Plastic surgeons

© Alcohol Medical Scholars Program 47

Page 48: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Rx Outcomes

80% w/o gender dysphoria

75% ↓ ↓ anxiety & depression

80% quality of life48

© Alcohol Medical Scholars Program

Page 49: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

Summary

Be familiar w/ changing terms

Being transgender not = pathology

Dysphoria needs interventions

Higher rates of psychiatric diagnosis

Be mindful of Rx barriers49

© Alcohol Medical Scholars Program

Page 50: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

ResourcesWorld Professional Association for

Transgender Health (www.wpath.org)

Center of Excellence for Transgender Health (www.transhelath.ucsf.edu)

American Psychiatric Association (www.psych.org)

American Academy of Child & Adolescent Psychiatry (www.aacap.org)

American Academy of Pediatrics (www.aap.org)

50© Alcohol Medical Scholars Program

Page 51: Substance Use in Transgender Individuals Myo Thwin Myint, M.D., F.A.A.P. Department of Psychiatry & Behavioral Sciences Department of Pediatrics Tulane

© Alcohol Medical Scholars Program 51